Press Announcements

Auretics Launched its Own Researched Herbal Cough Syrup – Sedoril

Auretics Limited, India’s largest online retail platform announced the launch of its own researched Herbal Cough syrup – Sedoril. The 100ml Herbal Cough Syrup is researched & manufactured by their GMP & ISO certified Partners. It is effective for expelling excessive Kapha. It helps in the management of respiratory conditions such as Bronchial Asthma, eases […]

Employees IIT Madras Research Park MediBuddy healthcare partners
Digital Health News

To keep employees in good health, IIT Madras Research Park opt for MediBuddy as their healthcare partner

With a vision to uphold its inherent commitment to ensure the overall wellbeing of all employees, IIT Madras Research Park (IITMRP) partners with MediBuddy, India’s largest digital healthcare platform to provide wide-ranging healthcare benefits. Keeping employee wellbeing a priority, IIT-M Research Park has opted for the MediBuddy Gold subscription for comprehensive healthcare benefits for all […]

Digital Health News

SRL Diagnostics and Roche Diagnostics India Partner to Unveil Laboratory of the Future at Fortis Memorial Research Institute

SRL Diagnostics, the largest Pathology chain in the country, is all set to transform its lab at Fortis Memorial Research Institute with Roche Diagnostics’ integrated analyser series.  With this installation, SRL Diagnostics is well on the path to establishing an Integrated Core Lab. This integration will bring enormous benefits to SRL and its patients. The […]

Hospital Updates

New Research Reveals Top Three Barriers Keeping Children from Cataract Treatment in India

The eye care nonprofit Orbis International announces its collaboration on new research published in the latest issue of the top-tier peer-reviewed medical journal PLOS ONE. The research outlines the findings of in-depth interviews conducted with parents and caregivers across India that were used to determine the top barriers to accessing sight-saving cataract treatment for their […]

Drug Updates

Eyestem Research moves one step closer to finding a treatment for Dry AMD

Eyestem Research, India’s leading cell therapy company, announces the successful completion of its dose-ranging study in animals for Eyecyte-RPE. Eyecyte-RPE is a suspension of Retinal Pigment Epithelium Cells for treatment of Dry Age-Related Macular Degeneration. 170 M people worldwide suffer from this disease, 40 M of which are in India. Eyestem Research is one of […]

Digital Health News

Lifebit partners with NIHR Cambridge Biomedical Research Centre to launch the CYNAPSE platform for next-generation genomics research

Lifebit today announces a long-term partnership where Lifebit’s technology, Lifebit CloudOS, will power a cloud-based Trusted Research Environment (TRE) to serve as the scalable and secure data management and analysis platform for researchers at the National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre (BRC). As one of the leading UK biomedical research organisations, […]

Pandemic Pulse

Phase 3 clinical trial results of Coronavir (favipiravir) published in US Journal

The American Journal of Translational Research has published successful results of the Phase 3 clinical trial of Coronavir (INN: favipiravir). This study aimed to evaluate the efficacy and safety of favipiravir for treatment of mild to moderate COVID-19 in outpatients and hospitalized patients. In an open-label, randomized, active-controlled clinical trial involving 168 patients with mild to moderate […]

Drug Updates

New Research Finds Challenges in Symptom Recognition and Diagnostic Testing can impact Patient Satisfaction for People with Vascular Disease

Abbott today released new global market research from its Beyond Intervention initiative, the company’s multi-year global research program designed to examine the vascular patient experience from the perspectives of patients, physicians and healthcare leaders. The latest research focuses on challenges that arise for physicians and patients during the earliest stages of the patient journey, uncovering […]

Drug Updates

Boehringer Ingelheim Acquires Abexxa Biologics to Further Expand its Research Efforts in Cancer Immunology and Novel Immunotherapeutic Approaches

Boehringer Ingelheim today announced the acquisition of Abexxa Biologics Inc., a biopharmaceutical company taking a new approach in the fields of immuno-oncology and oncology research to develop the next generation of precision medicines designed to revolutionize cancer treatments. The acquisition will allow Boehringer Ingelheim to access Abexxa’s expertise in targeting cancer-specific proteins that are located […]